Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Recombinant Protein Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novo Nordisk
Pharmingen
Ortho Biotech
Merck Serono
SL PHARM
Amgen
Roche
Ankebio
NCPC
Heng Rui
Abcam
Eli Lilly
Kyowa Hakko Kirin
By Type:
Recombinant RNA
Recombinant DNA
By Application:
Other
Pharmaceutical Industry
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Recombinant Protein Drugs Market Overview 2018-2029
-
1.1 China Recombinant Protein Drugs Industry Development Overview
-
1.2 China Recombinant Protein Drugs Industry Development History
-
1.3 China Recombinant Protein Drugs Industry Market Size (2018-2029)
-
1.4 China Recombinant Protein Drugs Market Analysis by Type from Production Side
-
1.4.1 China Recombinant Protein Drugs Production Volume, Production Value and Growth Rate of Recombinant RNA (2018-2029)
-
1.4.2 China Recombinant Protein Drugs Production Volume, Production Value and Growth Rate of Recombinant DNA (2018-2029)
-
1.5 China Recombinant Protein Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.2 China Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate of Pharmaceutical Industry (2018-2029)
-
1.6 China Recombinant Protein Drugs Market Analysis by Region
-
1.6.1 North China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Recombinant Protein Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Recombinant Protein Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Recombinant Protein Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Recombinant Protein Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Recombinant Protein Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Recombinant Protein Drugs Industry Development
Chapter 3 Recombinant Protein DrugsIndustry Chain Analysis
-
3.1 Recombinant Protein Drugs Industry Chain
-
3.2 Recombinant Protein Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Recombinant Protein Drugs Market
-
3.3 Recombinant Protein Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Recombinant Protein Drugs Market
Chapter 4 China Recombinant Protein Drugs Market, by Type
-
4.1 China Recombinant Protein Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Recombinant Protein Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Recombinant Protein Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Recombinant Protein Drugs Production Volume and Growth Rate of Recombinant RNA
-
4.5.2 China Recombinant Protein Drugs Production Volume and Growth Rate of Recombinant DNA
Chapter 5 China Recombinant Protein Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Recombinant Protein Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Recombinant Protein Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Recombinant Protein Drugs Market Size and Growth Rate of Other
-
5.5.2 China Recombinant Protein Drugs Market Size and Growth Rate of Pharmaceutical Industry
Chapter 6 China Recombinant Protein Drugs Market, by Region
-
6.1 China Recombinant Protein Drugs Production Volume and Production Value, by Region
-
6.2 China Recombinant Protein Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Recombinant Protein Drugs Market Analysis
-
7.1 North China Recombinant Protein Drugs Market, by Type
-
7.2 North China Recombinant Protein Drugs Market, by Application
Chapter 8 Central China Recombinant Protein Drugs Market Analysis
-
8.1 Central China Recombinant Protein Drugs Market, by Type
-
8.2 Central China Recombinant Protein Drugs Market, by Application
Chapter 9 South China Recombinant Protein Drugs Market Analysis
-
9.1 South China Recombinant Protein Drugs Market, by Type
-
9.2 South China Recombinant Protein Drugs Market, by Application
Chapter 10 East China Recombinant Protein Drugs Market Analysis
-
10.1 East China Recombinant Protein Drugs Market, by Type
-
10.2 East China Recombinant Protein Drugs Market, by Application
Chapter 11 Northeast China Recombinant Protein Drugs Market Analysis
-
11.1 Northeast China Recombinant Protein Drugs Market, by Type
-
11.2 Northeast China Recombinant Protein Drugs Market, by Application
Chapter 12 Southwest China Recombinant Protein Drugs Market Analysis
-
12.1 Southwest China Recombinant Protein Drugs Market, by Type
-
12.2 Southwest China Recombinant Protein Drugs Market, by Application
Chapter 13 Northwest China Recombinant Protein Drugs Market Analysis
-
13.1 Northwest China Recombinant Protein Drugs Market, by Type
-
13.2 Northwest China Recombinant Protein Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Novo Nordisk
-
14.1.1 Novo Nordisk Company Profile
-
14.1.2 Novo Nordisk Recombinant Protein Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pharmingen
-
14.2.1 Pharmingen Company Profile
-
14.2.2 Pharmingen Recombinant Protein Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Ortho Biotech
-
14.3.1 Ortho Biotech Company Profile
-
14.3.2 Ortho Biotech Recombinant Protein Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Merck Serono
-
14.4.1 Merck Serono Company Profile
-
14.4.2 Merck Serono Recombinant Protein Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 SL PHARM
-
14.5.1 SL PHARM Company Profile
-
14.5.2 SL PHARM Recombinant Protein Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Amgen
-
14.6.1 Amgen Company Profile
-
14.6.2 Amgen Recombinant Protein Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Roche
-
14.7.1 Roche Company Profile
-
14.7.2 Roche Recombinant Protein Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Ankebio
-
14.8.1 Ankebio Company Profile
-
14.8.2 Ankebio Recombinant Protein Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 NCPC
-
14.9.1 NCPC Company Profile
-
14.9.2 NCPC Recombinant Protein Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Heng Rui
-
14.10.1 Heng Rui Company Profile
-
14.10.2 Heng Rui Recombinant Protein Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Abcam
-
14.11.1 Abcam Company Profile
-
14.11.2 Abcam Recombinant Protein Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Eli Lilly
-
14.12.1 Eli Lilly Company Profile
-
14.12.2 Eli Lilly Recombinant Protein Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Kyowa Hakko Kirin
-
14.13.1 Kyowa Hakko Kirin Company Profile
-
14.13.2 Kyowa Hakko Kirin Recombinant Protein Drugs Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Recombinant Protein Drugs Industry Research Conclusions
-
15.2 Recombinant Protein Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Recombinant Protein Drugs Industry Market Size (2018-2029)
-
Figure China Recombinant Protein Drugs Production Volume, Production Value and Growth Rate of Recombinant RNA (2018-2029)
-
Figure China Recombinant Protein Drugs Production Volume, Production Value and Growth Rate of Recombinant DNA (2018-2029)
-
Figure China Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Recombinant Protein Drugs Sales Volume, Sales Value and Growth Rate of Pharmaceutical Industry (2018-2029)
-
Figure North China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Recombinant Protein Drugs Market Size and Growth Rate from 2018-2029
-
Figure Recombinant Protein Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Recombinant Protein Drugs Market Share by Type in 2018
-
Figure China Recombinant Protein Drugs Market Share by Type in 2023
-
Figure China Recombinant Protein Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Recombinant Protein Drugs Production Volume and Growth Rate of Recombinant RNA (2018-2023)
-
Figure China Recombinant Protein Drugs Production Volume and Growth Rate of Recombinant DNA (2018-2023)
-
Figure China Recombinant Protein Drugs Market Share by Application in 2018
-
Figure China Recombinant Protein Drugs Market Share by Application in 2023
-
Figure China Recombinant Protein Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Recombinant Protein Drugs Market Size and Growth Rate of Other (2018-2023)
-
Figure China Recombinant Protein Drugs Market Size and Growth Rate of Pharmaceutical Industry (2018-2023)
-
Table China Recombinant Protein Drugs Production Volume by Region (2018-2023)
-
Table China Recombinant Protein Drugs Production Volume Share by Region (2018-2023)
-
Figure China Recombinant Protein Drugs Production Volume Share by Region (2018-2023)
-
Table China Recombinant Protein Drugs Production Value by Region (2018-2023)
-
Table China Recombinant Protein Drugs Production Value Share by Region (2018-2023)
-
Figure China Recombinant Protein Drugs Production Value Share by Region (2018-2023)
-
Table China Recombinant Protein Drugs Sales Volume by Region (2018-2023)
-
Table China Recombinant Protein Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Recombinant Protein Drugs Sales Volume Share by Region (2018-2023)
-
Table China Recombinant Protein Drugs Sales Value by Region (2018-2023)
-
Table China Recombinant Protein Drugs Sales Value Share by Region (2018-2023)
-
Figure China Recombinant Protein Drugs Sales Value Share by Region (2018-2023)
-
Table North China Recombinant Protein Drugs Production Volume by Type (2018-2023)
-
Table North China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Table North China Recombinant Protein Drugs Sales Volume by Application (2018-2023)
-
Table North China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Recombinant Protein Drugs Production Volume by Type (2018-2023)
-
Table Central China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Recombinant Protein Drugs Sales Volume by Application (2018-2023)
-
Table Central China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Recombinant Protein Drugs Production Volume by Type (2018-2023)
-
Table South China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Table South China Recombinant Protein Drugs Sales Volume by Application (2018-2023)
-
Table South China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Recombinant Protein Drugs Production Volume by Type (2018-2023)
-
Table East China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Table East China Recombinant Protein Drugs Sales Volume by Application (2018-2023)
-
Table East China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Recombinant Protein Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Recombinant Protein Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Recombinant Protein Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Recombinant Protein Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Recombinant Protein Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Recombinant Protein Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Recombinant Protein Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Recombinant Protein Drugs Sales Volume Share by Application (2018-2023)
-
Table Novo Nordisk Company Profile
-
Table Novo Nordisk Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Pharmingen Company Profile
-
Table Pharmingen Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Ortho Biotech Company Profile
-
Table Ortho Biotech Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck Serono Company Profile
-
Table Merck Serono Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table SL PHARM Company Profile
-
Table SL PHARM Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Ankebio Company Profile
-
Table Ankebio Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table NCPC Company Profile
-
Table NCPC Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Heng Rui Company Profile
-
Table Heng Rui Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Abcam Company Profile
-
Table Abcam Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
Table Kyowa Hakko Kirin Company Profile
-
Table Kyowa Hakko Kirin Recombinant Protein Drugs Revenue, Price and Gross (2018-2023)
-
